logo

VCYT

Veracyte·NASDAQ
--
--(--)
--
--(--)
5.50 / 10
Netural

Fundamental scoring 5.5/10 shows fair quality. Strengths include Profit‑MV, Cash‑MV, ROA and high operating cash flow, while Asset‑MV and EBIT/Revenue are weak. Net profit ratios are mixed, yielding a selective outlook that leans slightly bullish on cash generation.

Fundamental(5.5)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-1.02
Score2/3
Weight10.72%
1M Return1.21%
ROA (%)
Value4.90
Score2/3
Weight6.22%
1M Return0.64%
Net cash flow from operating activities / Operating revenue (%)
Value26.36
Score2/3
Weight14.78%
1M Return1.48%
Profit-MV
Value-0.10
Score2/3
Weight31.90%
1M Return3.09%
Annualized net profit margin on total assets (%)
Value4.90
Score2/3
Weight6.22%
1M Return0.64%
EBIT / Total operating revenue (%)
Value-1049.47
Score2/3
Weight0.95%
1M Return0.10%
Asset-MV
Value-0.55
Score1/3
Weight3.41%
1M Return0.38%
Net profit / Total operating revenue (%)
Value12.83
Score2/3
Weight12.64%
1M Return1.26%
Cash-MV
Value-0.55
Score3/3
Weight31.83%
1M Return2.92%
Net profit / Total profit (%)
Value97.29
Score1/3
Weight-18.68%
1M Return-2.39%
Is VCYT undervalued or overvalued?
  • VCYT scores 5.50/10 on fundamentals and holds a Fair valuation at present. Backed by its 5.34% ROE, 12.83% net margin, 38.80 P/E ratio, 1.97 P/B ratio, and 162.50% earnings growth, these metrics solidify its Netural investment rating.